DBV Technologies SA
F:DBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DBV Technologies SA
F:DBV
|
FR |
|
C
|
Celcuity Inc
NASDAQ:CELC
|
US |
|
R
|
Renasant Corp
F:RN6
|
US |
|
StepStone Group Inc
NASDAQ:STEP
|
US |
|
Patriot Battery Metals Inc
ASX:PMT
|
CA |
|
P
|
Preferred Apartment Communities Inc
F:P2A
|
US |
|
Mastercraft Boat Holdings Inc
NASDAQ:MCFT
|
US |
|
Hilton Worldwide Holdings Inc
NYSE:HLT
|
US |
|
I
|
Igloo Corp
KOSDAQ:067920
|
KR |
|
Garofalo Health Care SpA
MIL:GHC
|
IT |
|
Red Sky Energy Ltd
ASX:ROG
|
AU |
|
T
|
Thai Beverage PCL
OTC:TBVPY
|
TH |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
Yunnan Yuntianhua Co Ltd
SSE:600096
|
CN |
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
Discovex Resources Ltd
ASX:DCX
|
AU |
|
S
|
Steakholder Foods Ltd
NASDAQ:STKH
|
IL |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Comfortdelgro Corporation Ltd
SGX:C52
|
SG |
Bankruptcy Probability
DBV Technologies SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DBV Technologies SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
DBV Technologies SA
PAR:DBV
|
844.4m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DBV Technologies SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DBV Technologies SA has total debt of 5.4m USD. This includes both short-term (0 USD) and long-term (5.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
